Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial
![Written contribution from the European CanCer Organisation (ECCO) to agenda item 5(g) Accelerating primary health Written contribution from the European CanCer Organisation (ECCO) to agenda item 5(g) Accelerating primary health](https://cdn.who.int/media/images/librariesprovider2/default-album/joint-statement---ecco-age-cotec-efad-iapo-iahpc-studiorum-wfot-5(g).tmb-479v.png?sfvrsn=483c18db_1)
Written contribution from the European CanCer Organisation (ECCO) to agenda item 5(g) Accelerating primary health
![ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach](https://researchoutreach.org/wp-content/uploads/2018/06/4944_ECCO2018_125mm_x_70mm_v1_OL_HR.jpg)
ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach
![Agnese Abolina email address & phone number | European Cancer Organisation Head of Communication and Community contact information - RocketReach Agnese Abolina email address & phone number | European Cancer Organisation Head of Communication and Community contact information - RocketReach](https://d1hbpr09pwz0sk.cloudfront.net/profile_pic/agnese-abolina-e7ec2bab.jpg)